Related Experiment Video

Updated: Mar 25, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.9K

Striking the right balance with type I interferon signalling in cancer

Thomas B Chadwick1,2, Joan So1,2, Paul J Hertzog3,4

  • 1Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.

Nature Reviews. Cancer
|March 24, 2026
PubMed

Insights

Type I interferons (IFNs) show promise in cancer therapy but face challenges. Understanding their complex roles and tumor-intrinsic mechanisms is key to improving treatment efficacy and overcoming resistance.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Type I interferons (IFNs), including IFNα and IFNβ, are crucial for anti-tumor immunity and enhancing cancer therapies.
  • Clinical success of IFN-based treatments in solid tumors is limited by toxicity and efficacy issues.

Purpose of the Study:

  • To review current understanding of type I IFN regulation and function in cancer.
  • To focus on tumor-intrinsic mechanisms governing canonical and chronic signaling pathways.
  • To explore how these pathways impact immune surveillance, metastasis, and treatment response.

Main Methods:

  • Review of recent scientific literature on type I IFNs in cancer.
  • Analysis of tumor-intrinsic mechanisms controlling IFN signaling.
  • Examination of age-related factors influencing IFN responses.

Main Results:

  • Type I IFNs exhibit dual immune-stimulatory and immune-suppressive roles within tumors.
  • Oncogenic signaling, chromatin state, and the tumor microenvironment modulate IFN activity.
  • Age-related changes like immunosenescence affect type I IFN signaling and therapeutic outcomes.

Conclusions:

  • Dissecting transcriptional, epigenetic, and signaling mechanisms of type I IFN responses is essential.
  • Actionable strategies can be developed to reprogram tumor IFN activity.
  • Improved understanding will enhance therapeutic responses in cancer patients.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.6K
A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF311:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

12.6K

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
16
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.0K